Obinutuzumab does not improve complete methabolic response but does not compromise mobilization or engraftment of autologous peripheral blood stem cells in diffuse large B cell lymphoma: Results from a fondazione italiana linfomi prospective phase II study (the GIOTTO study)-Reference-Cited by-同舟云学术

Obinutuzumab does not improve complete methabolic response but does not compromise mobilization or engraftment of autologous peripheral blood stem cells in diffuse large B cell lymphoma: Results from a fondazione italiana linfomi prospective phase II study (the GIOTTO study)

Published:2022-06-05 Issue:4 Volume:40 Page:609-616
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Rigacci Luigi¹²,Battistini Roberta¹,Kovalchuk Sofia²,Zoli Valerio¹,Puccini Benedetta²,Evangelista Andrea³,Arcaini Luca⁴⁵,Flenghi Leonardo⁶,Visco Carlo⁷^ORCID,Mian Michael⁸,Di Rocco Alice⁹,Peracchio Claudia¹⁰,Gotti Manuel⁴,Tisi Maria Chiara⁷,Palombi Francesca¹¹,Pozzi Samantha¹²,Gioia Daniela¹⁰,Viero Piera¹³,Martelli Maurizio⁹

Affiliation:

1. UOC Hematology and Stem Cell Transplantation AO San Camillo Forlanini Roma Italy

2. SOD Hematology AOU Careggi Firenze Italy

3. Unit of Clinical Epidemiology CPO Piemonte AOU Città della Salute e della Scienza di Torino Torino Italy

4. Policlinico San Matteo Pavia Fondazione IRCCS Pavia Italy

5. Departement of Molecular Medicine University of Pavia Pavia Italy

6. Institute of Hematology Ospedale S. Maria della Misericordia University of Perugia Perugia Italy

7. Hematology Unit Ospedale Vicenza Venezia Italy

8. Division of Hematology and BMT General Hospital of Bolzano Bolzano Italy

9. Department of Cellular Biotechnologies and Hematology Hematology Unit “Sapienza” University of Rome Rome Italy

10. Fondazione Italiana Linfomi ONLUS Alessandria Italy

11. UOSD Ematologia e Trapianti Istituto Nazionale Tumori Regina Elena IFO Roma Italy

12. UOC Ematologia Azienda Ospedaliero Universitaria Modena Modena Italy

13. UOC Ematologia dell'Ospedale dell'Angelo Venezia Italy

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.3028

Reference24 articles.

1. 2016 US lymphoid malignancy statistics by World Health Organization subtypes

2. Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

3. Ifosfamide, Carboplatin, and Etoposide: A Highly Effective Cytoreduction and Peripheral-Blood Progenitor-Cell Mobilization Regimen for Transplant-Eligible Patients With Non-Hodgkin's Lymphoma